Hims & Hers Health (HIMS) is showing powerful bullish momentum after announcing affordable access to Wegovy, backed by Q1 earnings that doubled sales and net income year-over-year. With expanding healthcare partnerships and strong technical support, HIMS is setting up for a potential breakout.
watchlist
